BASF introduces new solutions for the personal care market
Wax-based and readily biodegradable: Euperlan OP White and Cegesoft Peel.
At SCS Formulate on 13 & 14 November in Coventry, BASF will share stand 500 with its European distribution organization BTC Europe and present the latest solutions to meet the demands of the personal care market.
Readily biodegradable, wax-based opacifier dispersion and exfoliating beads for personal care products
BASF Care Creations will showcase two new products that answer the needs of today’s environmentally conscious consumers. “We are constantly seeking innovative and more sustainable solutions for the personal care industry. Consumer trends and needs clearly show us the way. With our new ingredients Euperlan OP White and Cegesoft Peel we can help our customers to develop winning products supporting both the consumers’ well-being and eco-conscience,” said Dirk Mampe, Vice President Business Management Personal Care Solutions Europe.
Euperlan OP White is a wax-based, readily biodegradable and cold processable opacifier dispersion with a superior white appearance for surfactant formulations. The product meets today’s demand for ecological friendly ingredients and its unique properties make it particularly suitable for eco-label conforming skin and hair cleansing formulations. BASF is the leading supplier of cold processable wax dispersions for personal care that provide optical effects in rinse off products. Euperlan OP White complements BASF’s current portfolio of pearlizing wax dispersions and can be used as an alternative to synthetic polymeric opacifiers.
Cegesoft Peel consists of round wax beads that provide a gentle and mild exfoliation. Mainly derived from natural and renewable resources, Cegesoft Peel is a readily biodegradable and environmentally friendly alternative to sharp-edged abrasives and non-degradable beads (often referred to as microplastic beads).
Hyalurosmooth – counteracting harmful effects of daily stress
Daily stresses are known to translate into cutaneous stress, with cortisol as its main mediator. Hyalurosmooth represses the damaging impact of cortisol on the skin, restoring collagen type I and hyaluronic acid that are affected. Bringing the positive effects of a mindful lifestyle – rested from the inside – Hyalurosmooth helps the skin recover its hydration and radiance. Extracted from the Indian Cassia angustifolia, Hyalurosmooth is IECIC-listed.
As part of the Inspire presentation program, Axel Boettcher from BTC Europe will be presenting new data on Hyalurosmooth.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.